Header Logo

Colin Menezes

Concepts (203)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tuberculosis
8
2022
543
1.750
Why?
Text Messaging
2
2022
25
1.440
Why?
Stavudine
3
2013
78
1.180
Why?
HIV Infections
21
2022
5097
1.130
Why?
Anti-HIV Agents
6
2021
1324
1.110
Why?
Humans
38
2022
14537
0.860
Why?
Adult
24
2022
5913
0.830
Why?
South Africa
29
2022
7596
0.830
Why?
Male
25
2022
6754
0.820
Why?
Adenine
2
2013
91
0.810
Why?
Antitubercular Agents
3
2021
322
0.750
Why?
Chemical and Drug Induced Liver Injury
1
2021
12
0.750
Why?
Female
25
2022
9103
0.720
Why?
Students, Medical
1
2020
14
0.710
Why?
Liver Cirrhosis
1
2020
28
0.710
Why?
Lost to Follow-Up
2
2020
62
0.700
Why?
Hepacivirus
1
2020
37
0.700
Why?
Hepatitis C, Chronic
1
2020
26
0.700
Why?
Allied Health Personnel
1
2020
6
0.700
Why?
Community-Institutional Relations
1
2019
6
0.680
Why?
Neurocysticercosis
1
2019
3
0.670
Why?
Magnetic Resonance Imaging
1
2019
37
0.660
Why?
Tomography, X-Ray Computed
1
2019
61
0.660
Why?
Retrospective Studies
8
2022
799
0.660
Why?
Malaria
1
2021
213
0.640
Why?
Attitude of Health Personnel
1
2020
106
0.630
Why?
Middle Aged
14
2022
3601
0.620
Why?
Coinfection
3
2019
276
0.600
Why?
Antiretroviral Therapy, Highly Active
5
2013
472
0.520
Why?
Echinococcosis
5
2013
6
0.510
Why?
Wound Infection
1
2015
2
0.500
Why?
Drug Resistance, Microbial
1
2015
26
0.500
Why?
Burns
1
2015
12
0.500
Why?
Phosphorous Acids
1
2013
14
0.440
Why?
Tuberculosis, Lymph Node
1
2013
8
0.430
Why?
Health Services Accessibility
4
2020
280
0.430
Why?
HIV-Associated Lipodystrophy Syndrome
1
2013
8
0.430
Why?
Reconstructive Surgical Procedures
1
2013
6
0.420
Why?
Bacteriological Techniques
1
2013
54
0.410
Why?
Adipocytes
1
2012
23
0.410
Why?
Organophosphonates
1
2012
45
0.400
Why?
Risk Factors
6
2021
1475
0.390
Why?
Reverse Transcriptase Inhibitors
1
2012
118
0.390
Why?
Molecular Diagnostic Techniques
1
2013
132
0.390
Why?
Aged
6
2022
1740
0.370
Why?
Meningitis, Cryptococcal
2
2022
16
0.370
Why?
Prospective Studies
5
2021
1160
0.360
Why?
Tertiary Care Centers
2
2021
80
0.350
Why?
Severity of Illness Index
2
2021
253
0.350
Why?
Meningitis, Bacterial
2
2022
38
0.270
Why?
Genotype
2
2020
442
0.250
Why?
Cryptococcosis
2
2022
17
0.240
Why?
Hospital Mortality
2
2022
95
0.230
Why?
AIDS-Related Opportunistic Infections
2
2020
195
0.230
Why?
Flucytosine
2
2022
4
0.220
Why?
Antifungal Agents
2
2022
40
0.220
Why?
Comorbidity
2
2022
188
0.210
Why?
DNA, Mitochondrial
2
2013
31
0.210
Why?
Glucose
2
2013
45
0.210
Why?
Dose-Response Relationship, Drug
2
2013
125
0.210
Why?
Lipid Metabolism
2
2013
44
0.210
Why?
Meningitis, Meningococcal
1
2022
17
0.200
Why?
Inflammation
2
2013
104
0.200
Why?
ROC Curve
2
2020
51
0.200
Why?
Meningitis, Pneumococcal
1
2022
20
0.200
Why?
Prevalence
6
2021
1192
0.200
Why?
Follow-Up Studies
3
2019
370
0.200
Why?
Platelet Count
2
2020
14
0.200
Why?
Technology
1
2022
4
0.200
Why?
Alveolar Epithelial Cells
1
2022
4
0.200
Why?
Neisseria meningitidis
1
2022
36
0.200
Why?
Extensively Drug-Resistant Tuberculosis
2
2013
20
0.190
Why?
Leprosy
1
2021
3
0.190
Why?
Biomarkers
2
2013
327
0.190
Why?
Travel
1
2021
21
0.190
Why?
Health Personnel
2
2021
231
0.190
Why?
Moral Obligations
1
2020
1
0.180
Why?
Patient Rights
1
2020
3
0.180
Why?
Morals
1
2020
5
0.180
Why?
Lamivudine
2
2013
89
0.180
Why?
Aspartate Aminotransferases
1
2020
10
0.180
Why?
Area Under Curve
1
2020
20
0.180
Why?
Ribavirin
1
2020
15
0.180
Why?
Interferon-alpha
1
2020
15
0.180
Why?
Sustained Virologic Response
1
2020
22
0.180
Why?
Polyethylene Glycols
1
2020
49
0.180
Why?
Recombinant Proteins
1
2020
73
0.180
Why?
Invasive Fungal Infections
1
2020
2
0.170
Why?
Sample Size
1
2019
4
0.170
Why?
Program Evaluation
1
2020
89
0.170
Why?
Diabetes Mellitus
1
2022
146
0.170
Why?
Drug Therapy, Combination
1
2020
279
0.170
Why?
Antiviral Agents
1
2020
111
0.170
Why?
Social Stigma
1
2020
80
0.170
Why?
Pandemics
1
2022
296
0.160
Why?
Biopsy
1
2019
38
0.160
Why?
Kidney
1
2019
46
0.160
Why?
Kidney Diseases
1
2019
38
0.160
Why?
Counseling
1
2020
143
0.160
Why?
Cross-Sectional Studies
4
2022
1422
0.160
Why?
Referral and Consultation
3
2013
57
0.160
Why?
Hospitalization
1
2021
418
0.150
Why?
Tuberculosis, Pulmonary
2
2013
324
0.140
Why?
Hypertension
1
2022
419
0.140
Why?
Echinococcus
2
2013
5
0.130
Why?
Longitudinal Studies
2
2021
435
0.130
Why?
Proportional Hazards Models
2
2013
163
0.130
Why?
Incidence
2
2015
685
0.130
Why?
Burn Units
1
2015
5
0.130
Why?
Adolescent
4
2021
2985
0.120
Why?
Young Adult
4
2019
2498
0.120
Why?
Anti-Bacterial Agents
2
2015
293
0.120
Why?
Sensitivity and Specificity
2
2013
385
0.120
Why?
Bacteremia
1
2015
79
0.120
Why?
Intensive Care Units
1
2015
66
0.120
Why?
Surveys and Questionnaires
2
2013
563
0.110
Why?
Analysis of Variance
1
2013
64
0.110
Why?
Drug Substitution
1
2013
33
0.110
Why?
Alkynes
1
2013
117
0.110
Why?
Cyclopropanes
1
2013
123
0.110
Why?
Anthropometry
1
2013
102
0.110
Why?
Tuberculosis, Multidrug-Resistant
2
2013
226
0.110
Why?
Patient Care
1
2013
10
0.110
Why?
Hospitals, Urban
1
2013
23
0.100
Why?
Benzoxazines
1
2013
123
0.100
Why?
Health Services Needs and Demand
1
2013
57
0.100
Why?
HIV
2
2012
380
0.100
Why?
Gene Expression Profiling
1
2012
41
0.100
Why?
DNA Copy Number Variations
1
2012
22
0.100
Why?
Body Composition
1
2013
153
0.100
Why?
Medical Records Systems, Computerized
1
2011
1
0.100
Why?
Decision Support Systems, Clinical
1
2011
1
0.100
Why?
Triage
1
2011
11
0.100
Why?
Time Factors
1
2013
507
0.100
Why?
Tenofovir
1
2012
171
0.090
Why?
CD4-Positive T-Lymphocytes
1
2012
151
0.090
Why?
Zoonoses
1
2011
4
0.090
Why?
Communicable Diseases, Emerging
1
2011
6
0.090
Why?
RNA, Viral
1
2012
303
0.090
Why?
Academic Medical Centers
2
2020
30
0.080
Why?
Red-Cell Aplasia, Pure
1
2008
1
0.080
Why?
Treatment Outcome
4
2013
889
0.080
Why?
Acinetobacter Infections
1
2008
4
0.080
Why?
Acinetobacter baumannii
1
2008
11
0.080
Why?
Anticestodal Agents
1
2007
1
0.070
Why?
Cestode Infections
1
2007
1
0.070
Why?
Gardening
1
2007
2
0.070
Why?
Albendazole
1
2007
3
0.070
Why?
Treatment Refusal
1
2007
13
0.070
Why?
Occupational Exposure
1
2007
35
0.070
Why?
Animals
3
2013
1081
0.060
Why?
Anti-Retroviral Agents
1
2007
551
0.050
Why?
Fluconazole
1
2022
17
0.050
Why?
Haemophilus influenzae
1
2022
42
0.050
Why?
Biopsy, Large-Core Needle
1
2022
8
0.050
Why?
Hospitals
2
2013
103
0.050
Why?
Disease Progression
1
2022
154
0.050
Why?
Length of Stay
1
2022
43
0.050
Why?
Child
2
2021
2242
0.050
Why?
Real-Time Polymerase Chain Reaction
1
2022
90
0.050
Why?
Autopsy
1
2022
140
0.050
Why?
Africa South of the Sahara
2
2012
353
0.040
Why?
Primary Health Care
2
2013
240
0.040
Why?
Histoplasmosis
1
2020
1
0.040
Why?
Antigens, Fungal
1
2020
9
0.040
Why?
Inpatients
1
2020
30
0.040
Why?
Lipopolysaccharides
1
2020
37
0.040
Why?
Streptococcus pneumoniae
1
2022
336
0.040
Why?
Point-of-Care Systems
1
2020
91
0.040
Why?
Cohort Studies
1
2021
967
0.040
Why?
CD4 Lymphocyte Count
2
2012
656
0.040
Why?
Infant
1
2022
2244
0.030
Why?
Cattle
1
2013
28
0.030
Why?
Species Specificity
1
2013
49
0.030
Why?
Immunocompromised Host
1
2013
34
0.030
Why?
Echinococcus granulosus
1
2012
1
0.030
Why?
Treatment Failure
1
2013
175
0.030
Why?
Demography
1
2013
105
0.030
Why?
Logistic Models
1
2013
254
0.020
Why?
Aged, 80 and over
1
2013
468
0.020
Why?
Age Factors
1
2013
370
0.020
Why?
Neglected Diseases
1
2011
1
0.020
Why?
Livestock
1
2011
1
0.020
Why?
Algorithms
1
2011
106
0.020
Why?
Survival Rate
1
2010
96
0.020
Why?
Microbial Sensitivity Tests
1
2010
198
0.020
Why?
Viral Load
1
2013
819
0.020
Why?
Hematocrit
1
2008
6
0.020
Why?
Leukocyte Count
1
2008
24
0.020
Why?
Thienamycins
1
2008
6
0.020
Why?
Dexamethasone
1
2008
13
0.020
Why?
Ceftriaxone
1
2008
13
0.020
Why?
Anti-Inflammatory Agents
1
2008
39
0.020
Why?
Hemoptysis
1
2007
4
0.020
Why?
Cross Infection
1
2008
52
0.020
Why?
Hospitals, County
1
2007
2
0.020
Why?
Hepatitis C
1
2007
37
0.020
Why?
Poverty Areas
1
2007
20
0.020
Why?
Community-Acquired Infections
1
2008
102
0.020
Why?
Sex Factors
1
2007
227
0.020
Why?
Socioeconomic Factors
1
2007
411
0.020
Why?
HIV Seropositivity
1
2007
265
0.020
Why?
Urban Population
1
2007
257
0.020
Why?
Menezes's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (203)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_